Vitamin E and human health: Rationale for determining recommended intake levels

被引:106
作者
Weber, P
Bendich, A
Machlin, LJ
机构
[1] Human Nutrition Research Division, Hoffmann-La Roche, Paramus, NJ
[2] Hoffmann-La Roche Inc., Paramus, NJ 07652-1429
关键词
vitamin E; requirements; cardiovascular disease; PUFA; human health; cancer; immunology;
D O I
10.1016/S0899-9007(97)00110-X
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The recent literature provides strong evidence that vitamin E intakes much higher than the current recommendations can contribute to and/or improve human health. In fact, the available data indicate that at higher-than-current recommended intake levels, vitamin E affects several functions related to human health. For example, Vitamin E is required to protect polyunsaturated fatty acids (PUFAs) against auto-oxidation. The amount of vitamin E needed to protect PUFAs against oxidative damage is at least 0.4-0.8 mg vitamin E per gram PUFAs and may be in excess of 1.5 mg/g when diets contain higher-than-average levels of long-chain PUFAs. Based upon studies of vitamin E kinetics and metabolism a daily vitamin E intake of 135-150 IU is suggested. Important functions such as protection against oxidative damage, immune response, and the propensity of platelets to adhere to the vessel wall are related to vitamin E intakes. Vitamin E intake of 40 IU/d was the least amount demonstrated to inhibit low-density lipoprotein oxidation; a dose-dependent effect was seen up to 800 IU/d. Vitamin E intakes of at least 60 IU/d enhanced immune responses and intakes of 200 IU-400 IU/d decreased platelet adhesion to the vessel wall. Based upon the effects of modulating these functions, it is hypothesized that vitamin E plays a pivotal role in the prevention of cardiovascular diseases. Indeed, many observational studies have reported vitamin E to reduce the risk of cardiovascular disease. Recent intervention studies corroborate these findings. Of equal importance, there is a solid body of literature that demonstrates that these and much higher vitamin E intakes are safe. (C) Elsevier Science Inc. 1997.
引用
收藏
页码:450 / 460
页数:11
相关论文
共 104 条
[1]  
ALAIMO K, 1988, 258 US DEP HLTH HUM
[2]  
Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501
[3]  
AMERY AKP, 1995, WHO TECH REP SER, V853, P1
[4]   FAMILIAL ISOLATED VITAMIN-E-DEFICIENCY - EXTENSIVE STUDY OF A LARGE FAMILY WITH A 5-YEAR THERAPEUTIC FOLLOW-UP [J].
AMIEL, J ;
MAZIERE, JC ;
BEUCLER, I ;
KOENIG, M ;
REUTENAUER, L ;
LOUX, N ;
BONNEFONT, D ;
FEO, C ;
LANDRIEU, P .
JOURNAL OF INHERITED METABOLIC DISEASE, 1995, 18 (03) :333-340
[5]  
[Anonymous], 1991, VITAMIN C VITAMIN IN
[6]  
[Anonymous], FREE RADICALS AGING
[7]  
[Anonymous], 1989, Recommended dietary allowances
[8]   COMPARISON OF PLASMA ALPHA-TOCOPHEROL AND GAMMA-TOCOPHEROL LEVELS FOLLOWING CHRONIC ORAL-ADMINISTRATION OF EITHER ALL-RAC-ALPHA-TOCOPHERYL ACETATE OR RRR-ALPHA-TOCOPHERYL ACETATE IN NORMAL ADULT MALE-SUBJECTS [J].
BAKER, H ;
HANDELMAN, GJ ;
SHORT, S ;
MACHLIN, LJ ;
BHAGAVAN, HN ;
DRATZ, EA ;
FRANK, O .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1986, 43 (03) :382-387
[9]  
BAKER H, 1980, NUTR REP INT, V21, P531
[10]   SAFETY OF ORAL INTAKE OF VITAMIN-E [J].
BENDICH, A ;
MACHLIN, LJ .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1988, 48 (03) :612-619